Fig. 2From: Clinical utility and cost modelling of the phi test to triage referrals into image-based diagnostic services for suspected prostate cancer: the PRIM (Phi to RefIne Mri) studyDecision curve analysis comparing the number of net benefits for detection of significant cancers for a range of risk threshold values and using different approaches (MRI-PSAd using a PSAd threshold of ≥ 0.15). MRI - magnetic resonance imaging, PSAd - PSA density, phi - Prostate Health IndexBack to article page